EUVIMEDEUVIMED entdecken
Crossref

Fungal β-Glucans as Immunomodulatory Agents in Cancer Therapy: Untapped Biotechnological Potentials

LE LAM NGOC DIEP

International Journal of Applied Science and Research · 2026 · 09 (04) · 100-115

DOI: 10.56293/ijasr.2026.7206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Applied Science and Research, 2026. Verfasst von LE LAM NGOC DIEP.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains one of the leading causes of mortality worldwide, with approximately 19.98 million new cases and 9.74 million cancer-related deaths reported in 2022, highlighting the urgent need for safer and more effective therapeutic strategies. Among naturally derived bioactive compounds, fungal β-glucans have attracted considerable attention because of their unique immunomodulatory properties and broad biotechnological potential. This review comprehensively summarizes recent advances in the structural characteristics, natural sources, biotechnological production, structureactivity relationships, immunomodulatory mechanisms, antitumor immune responses, and emerging therapeutic applications of fungal β-glucans in cancer management. Current evidence indicates that fungal β-glucans, primarily composed of β-(1→3)-linked glucan backbones with β-(1→6)-linked branches, activate innate and adaptive immunity through pattern-recognition receptors, particularly Dectin-1 and complement receptor 3, thereby enhancing macrophage polarization, dendritic cell maturation, natural killer cell cytotoxicity, CD8⁺ T-cell activation, and tumor microenvironment remodeling. Representative clinical studies involving 20-139 patients have further demonstrated improved survival, enhanced immune responses, increased natural killer cell activity, and improved objective response rates when fungal β-glucans were administered alone or in combination with conventional chemotherapy, radiotherapy, or immune checkpoint inhibitors. Furthermore, recent advances in fermentation technology, green extraction methods, nanotechnology, synthetic biology, and precision immunotherapy have considerably expanded the translational potential of fungal βglucans as immunotherapeutic adjuvants, drug delivery systems, and vaccine carriers. Collectively, fungal β-glucans represent a promising class of multifunctional biomolecules that bridge natural product biotechnology with modern cancer immunotherapy and provide substantial opportunities for future precision oncology and translational biomedical research.

Zitieren

APA

DIEP, L. L. N. (2026). Fungal β-Glucans as Immunomodulatory Agents in Cancer Therapy: Untapped Biotechnological Potentials. International Journal of Applied Science and Research, 09(04), 100-115. https://doi.org/10.56293/ijasr.2026.7206

Vancouver

DIEP LLN. Fungal β-Glucans as Immunomodulatory Agents in Cancer Therapy: Untapped Biotechnological Potentials. International Journal of Applied Science and Research. 2026;09(04):100-115. doi:10.56293/ijasr.2026.7206

BibTeX
@article{DIEP2026,
  author = {DIEP, LE LAM NGOC},
  title = {Fungal β-Glucans as Immunomodulatory Agents in Cancer Therapy: Untapped Biotechnological Potentials},
  journal = {International Journal of Applied Science and Research},
  year = {2026},
  volume = {09},
  number = {04},
  pages = {100--115},
  doi = {10.56293/ijasr.2026.7206}
}
Kostenlos starten →